A short isoform of human cytomegalovirus US3 functions as a dominant negative inhibitor of the full-length form

Journal of Virology

Volumn 80, Issue 11, 2006, Pages 5397-5404

  Shin, Jinwook ^a   Park, Boyoun ^a   Lee, Sungwook ^a   Kim, Youngkyun ^a   Biegalke, Bonita J ^c   Kang, Seongman ^b   Ahn, Kwangseog ^a  

^a Seoul National University   (South Korea)

^b Korea University   (South Korea)

^c OHIO UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN US3; TAPASIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; BINDING COMPETITION; CELL SURFACE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNOSURVEILLANCE; LYSIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RNA SPLICING; SURVIVAL; US3 GENE; VIRUS CELL INTERACTION; VIRUS GENE;

CYTOMEGALOVIRUS; GLYCOPROTEINS; HELA CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMEDIATE-EARLY PROTEINS; MEMBRANE PROTEINS;

HUMAN HERPESVIRUS 5;

EID: 33646743790     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02397-05     Document Type: Article

References (47)

1. Ahn, K., A. Angulo, P. Ghazal, P. A. Peterson, Y. Yang, and K. Fruh. 1996. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc. Natl. Acad. Sci. USA 93:10990-10995.
2. Ahn, K., A. Gruhler, B. Galocha, T. R. Jones, E. J. Wiertz, H. L. Ploegh, P. A. Peterson, Y. Yang, and K. Fruh. 1997. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6:613-621.
3. Andersson, M., S. Paabo, T. Nilsson, and P. A. Peterson. 1985. Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell 43:215-222.
4. Beck, S., and B. G. Barrell. 1988. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature 331:269-272.
5. Bennett, E. M., J. R. Bennink, J. W. Yewdell, and F. M. Brodsky. 1999. Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression. J. Immunol. 162:5049-5052.
6. Biegalke, B. J. 1999. Human cytomegalovirus US3 gene expression is regulated by a complex network of positive and negative regulators. Virology 261:155-164.
7. Biegalke, B. J. 1995. Regulation of human cytomegalovirus US3 gene transcription by a cis-repressive sequence. J. Virol. 69:5362-5367.
8. Biron, C. A., K. S. Byron, and J. L. Sullivan. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320:1731-1735.
9. Cosman, D., J. Mullberg, C. L. Sutherland, W. Chin, R. Armitage, W. Fanslow, M. Kubin, and N. J. Chalupny. 2001. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14:123-133.
10. Cox, J. H., J. R. Bennink, and J. W. Yewdell. 1991. Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation. J. Exp. Med. 174:1629-1637.
11. Fahnestock, M. L., I. Tamir, L. Narhi, and P. J. Bjorkman. 1992. Thermal stability comparison of purified empty and peptide-filled forms of a class I MHC molecule. Science 258:1658-1662.
12. Falk, C. S., M. Mach, D. J. Schendel, E. H. Weiss, I. Hilgert, and G. Hahn. 2002. NK cell activity during human cytomegalovirus infection is dominated by US2-11-mediated HLA class I down-regulation. J. Immunol. 169:3257-3266.
13. Ford, S., A. Antoniou, G. W. Butcher, and S. J. Powis. 2004. Competition for access to the rat major histocompatibility complex class I peptide-loading complex reveals optimization of peptide cargo in the absence of transporter associated with antigen processing (TAP) association. J. Biol. Chem. 279:16077-16082.
14. Fruh, K., Y. Yang, D. Arnold, J. Chambers, L. Wu, J. B. Waters, T. Spies, and P. A. Peterson. 1992. Alternative exon usage and processing of the major histocompatibility complex-encoded proteasome subunits. J. Biol. Chem. 267:22131-22140.
15. Gothie, E., D. E. Richard, E. Berra, G. Pages, and J. Pouyssegur. 2000. Identification of alternative spliced variants of human hypoxia-inducible factor-lalpha. J. Biol. Chem. 275:6922-6927.
16. Grandea, A. G., III, P. J. Lehner, P. Cresswell, and T. Spies. 1997. Regulation of MHC class I heterodimer stability and interaction with TAP by tapasin. Immunogenetics 46:477-483.
17. Grandea, A. G., III, and L. Van Kaer. 2001. Tapasin: an ER haperone that controls MHC class I assembly with peptide. Trends Immunol. 22:194-199.
18. Hengel, H., J. O. Koopmann, T. Flohr, W. Muranyi, E. Goulmy, G. J. Hammerling, U. H. Koszinowski, and F. Momburg. 1997. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6:623-632.
19. Jones, T. R., E. J. Wiertz, L. Sun, K. N. Fish, J. A. Nelson, and H. L. Ploegh. 1996. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc. Natl. Acad. Sci. USA 93:11327-11333.
20. Lee, S., B. Park, and K. Ahn. 2003. Determinant for endoplasmic reticulum retention in the luminal domain of the human cytomegalovirus US3 glycoprotein. J. Virol. 77:2147-2156.
21. Lee, S., J. Yoon, B. Park, Y. Jun, M. Jin, H. C. Sung, I. H. Kim, S. Kang, E. J. Choi, B. Y. Ahn, and K. Ahn. 2000. Structural and functional dissection of human cytomegalovirus US3 in binding major histocompatibility complex class I molecules. J. Virol. 74:11262-11269.
22. Lee, S. O., S. Hwang, J. Park, B. Park, B. S. Jin, S. Lee, E. Kim, S. Cho, Y. Kim, K. Cho, J. Shin, and K. Ahn. 2005. Functional dissection of HCMV US11 in mediating the degradation of MHC class I molecules. Biochem. Biophys. Res. Commun. 330:1262-1267.
23. Lilley, B. N., D. Tortorella, and H. L. Ploegh. 2003. Dislocation of a type I membrane protein requires interactions between membrane-spanning segments within the lipid bilayer. Mol. Biol. Cell 14:3690-3698.
24. Liu, W., Y. Zhao, and B. Biegalke. 2002. Analysis of human cytomegalovirus US3 gene products. Virology 301:32-42.
25. Ljunggren, H. G., and K. Karre. 1990. In search of the 'missing self: MHC molecules and NK cell recognition. Immunol. Today 11:237-244.
26. Lodoen, M. B., and L. L. Lanier. 2005. Viral modulation of NK cell immunity. Nat. Rev. Microbiol. 3:59-69.
27. Lybarger, L., X. Wang, M. Harris, and T. H. Hansen. 2005. Viral immune evasion molecules attack the ER peptide-loading complex and exploit ER-associated degradation pathways. Curr. Opin. Immunol. 17:71-78.
28. Mocarski, E. S., Jr. 2002. Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol. 10:332-339.
29. Neefjes, J. J., G. J. Hammerling, and F. Momburg. 1993. Folding and assembly of major histocompatibility complex class I heterodimers in the endoplasmic reticulum of intact cells precedes the binding of peptide. J. Exp. Med. 178:1971-1980.
30. Ortmann, B., J. Copeman, P. J. Lehner, B. Sadasivan, J. A. Herberg, A. G. Grandea, S. R. Riddell, R. Tampe, T. Spies, J. Trowsdale, and P. Cresswell. 1997. A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science 277:1306-1309.
31. Park, B., Y. Kim, J. Shin, S. Lee, K. Cho, K. Fruh, and K. Ahn. 2004. Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. Immunity 20:71-85.
32. Petersen, J. L., C. R. Morris, and J. C. Solheim. 2003. Virus evasion of MHC class I molecule presentation. J. Immunol. 171:4473-4478.
33. Purcell, A. W., J. J. Gorman, M. Garcia-Peydro, A. Paradela, S. R. Burrows, G. H. Talbo, N. Laham, C. A. Peh, E. C. Reynolds, J. A. Lopez De Castro, and J. McCluskey. 2001. Quantitative and qualitative influences of tapasin on the class I peptide repertoire. J. Immunol. 166:1016-1027.
34. Schoenhals, G. J., R. M. Krishna, A. G. Grandea III, T. Spies, P. A. Peterson, Y. Yang, and K. Fruh. 1999. Retention of empty MHC class I molecules by tapasin is essential to reconstitute antigen presentation in invertebrate cells. EMBO J. 18:743-753.
35. Schumacher, T. N., M. T. Heemels, J. J. Neefjes, W. M. Kast, C. J. Melief, and H. L. Ploegh. 1990. Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. Cell 62:563-567.
36. Spatz, S. J., E. C. Nordby, and P. C. Weber. 1996. Mutational analysis of ICP0R, a transrepressor protein created by alternative splicing of the ICP0 gene of herpes simplex virus type 1. J. Virol. 70:7360-7370.
37. Stasiv, Y., B. Kuzin, M. Regulski, T. Tully, and G. Enikolopov. 2004. Regulation of multimers via truncated isoforms: a novel mechanism to control nitric-oxide signaling. Genes Dev. 18:1812-1823.
38. Tenney, D. J., L. D. Santomenna, K. B. Goudie, and A. M. Colberg-Poley. 1993. The human cytomegalovirus US3 immediate-early protein lacking the putative transmembrane domain regulates gene expression. Nucleic Acids Res. 21:2931-2937.
39. Tomasec, P., V. M. Braud, C. Rickards, M. B. Powell, B. P. McSharry, S. Gadola, V. Cerundolo, L. K. Borysiewicz, A. J. McMichael, and G. W. Wilkinson. 2000. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287:1031.
40. Tortorella, D., B. E. Gewurz, M. H. Furman, D. J. Schust, and H. L. Ploegh. 2000. Viral subversion of the immune system. Annu. Rev. Immunol. 18:861-926.
41. Townsend, A., and H. Bodmer. 1989. Antigen recognition by class I-restricted T lymphocytes. Annu. Rev. Immunol. 7:601-624.
42. Turnquist, H. R., J. L. Petersen, S. E. Vargas, M. M. McIlhaney, E. Bedows, W. E. Mayer, A. G. Grandea III, L. Van Kaer, and J. C. Solheim. 2004. The Ig-like domain of tapasin influences intermolecular interactions. J. Immunol. 172:2976-2984.
43. Weber, P. C., S. J. Spatz, and E. C. Nordby. 1999. Stable ubiquitination of the ICP0R protein of herpes simplex virus type 1 during productive infection. Virology 253:288-298.
44. Weston, K. 1988. An enhancer element in the short unique region of human cytomegalovirus regulates the production of a group of abundant immediate early transcripts. Virology 162:406-416.
45. Wiertz, E. J., T. R. Jones, L. Sun, M. Bogyo, H. J. Geuze, and H. L. Ploegh. 1996. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84:769-779.
46. Wiertz, E. J., D. Tortorella, M. Bogyo, J. Yu, W. Mothes, T. R. Jones, T. A. Rapoport, and H. L. Ploegh. 1996. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384:432-438.
47. Williams, A. P., C. A. Peh, A. W. Purcell, J. McCluskey, and T. Elliott. 2002. Optimization of the MHC class I peptide cargo is dependent on tapasin. Immunity 16:509-520.